The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index; 39 of the 53 sources its claims cite were checked for support.
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Open accessAbstract
PRISMA 2020 is an updated reporting guideline for systematic reviews and meta-analyses.
Overview
CoChat Summary
TL;DR
PRISMA 2020 is an updated reporting guideline that replaces PRISMA 2009, providing a 27-item checklist, an expanded checklist, an abstract checklist, and revised flow diagrams for systematic reviews. It aims to help authors report transparently, completely, and accurately why a review was done, what they did, and what they found.
Key findings
- PRISMA 2020 replaces PRISMA 2009 and consists of a 27-item checklist, an expanded checklist, a 12-item abstract checklist, and revised flow diagrams for original and updated reviews.
- Development drew on a review of 60 documents providing reporting guidance, a survey of systematic review methodologists and journal editors (110 of 220 invited responded), a 21-member two-day meeting in September 2018, and feedback from 15 of 22 invited reviewers.
- Noteworthy changes include adding the abstract checklist, new certainty assessment items (#15 and #22), competing interests (#26), data/code availability (#27), and splitting synthesis methods and results into sub-items (#13a–13f and #20a–20d).
- PRISMA 2009 was cited in over 60,000 reports (Scopus, August 2020) and endorsed by almost 200 journals and systematic review organisations.
Methods
- The update adapted the EQUATOR Network’s guidance for developing health research reporting guidelines; it identified PRISMA 2009 items often reported incompletely, reviewed 60 guidance documents, and surveyed methodologists and journal editors.
- A 21-member, two-day in-person meeting was held in September 2018 in Edinburgh; an initial draft and five revisions were circulated to co-authors in 2019–2020, and 15 of 22 invited reviewers provided feedback on a preliminary checklist.
- The final version was approved and endorsed by all co-authors; complete development methods are described elsewhere.
Limitations
- Stated in the paper: PRISMA 2020 is not intended to guide systematic review conduct, assess conduct or methodological quality, or inform protocol reporting; updated and living reviews may require additional considerations.
- Stated in the paper: it is unclear which strategies increase adherence to reporting guidelines; of 31 proposed interventions, the effects of only 11 have been evaluated, mostly in observational studies at high risk of bias due to confounding.
- Evident from the text: PRISMA 2020 is a consensus-based reporting guideline, and the paper does not report empirical validation that PRISMA 2020 itself improves reporting or review outcomes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig 1 PRISMA 2020 flow diagram template for systematic reviews. The new design is adapted from flow diagrams proposed by Boers,[55] Mayo-Wilson et al.[56] and Stovold et al.[57] The boxes in grey should only be completed if applicable; otherwise they should be removed from the flow diagram. Note that a “report” could be a journal article, preprint, conference abstract, study register entry, clinical study report, dissertation, unpublished manuscript, government report or any other document providing relevant information.](/paper-figures/df3b831f32324677ad86f0f26e127d05/the-prisma-2020-statement-an-updated-guideline-for-reporting-systematic-reviews-figure-1.jpg)
Verification
Claims the paper makes
19 Valid · 0 Not valid · 1 Not checked · 18 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“We identified PRISMA 2009 items that were often reported incompletely by examining the results of studies investigating the transparency of reporting of published reviews.[17, 21, 36, 37]”
§ The PRISMA 2020 statement: An updated guideline for reporting systematic reviews > Development of PRISMA 2020
What the sources say
- Supportedcites [17] MJ Page, 2016, Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study, PLoS Med source
The Results section (“Reporting Characteristics of SRs”) reports how often published reviews completely, partially, or did not report characteristics such as review flow. The Discussion (“Explanation of Results and Implications”) states that reporting of many systematic reviews remains poor despite PRISMA 2009 and explains how individual PRISMA items may be reported incompletely. The citing authors’ identification of items is their own use of these findings. (LLM, conf=0.90)
- Supportedcites [21] MJ Page, 2017, Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review, Syst Rev source
The Methods section says the authors pooled studies measuring how often published systematic reviews adhered to each PRISMA item. The Results section identifies 11 items adhered to by fewer than 67% of reviews, supporting the claim that these studies revealed items often reported incompletely. Page numbers are not provided in our copy. (LLM, conf=0.94)
- Supportedcites [36] MJ Page, 2018, Reproducible research practices are underused in systematic reviews of biomedical interventions, J Clin Epidemiol source
The Discussion (p. 20) reports that summary statistics recommended by PRISMA were missing from 28% of index meta-analyses in the systematic reviews studied. The Introduction (p. 6) also identifies this as a PRISMA reporting item. This paper therefore provides evidence of incomplete reporting that the citing authors could use to identify items, without claiming that it identified every item itself. (LLM, conf=0.90)
- Supportedcites [37] MJ Page, 2018, Flaws in the application and interpretation of statistical analyses in systematic reviews of therapeutic interventions were common: a cross-sectional analysis, J Clin Epidemiol source
The Results (sections 3.5 and 3.6) document reporting omissions in published systematic reviews, including missing rationales for subgroup and sensitivity analyses. Section 4.3 connects statistical reporting to the PRISMA checklist. The citing authors’ identification of particular PRISMA 2009 items is their own use of these findings, not a claim that this paper identified those items. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, the publishing landscape has transformed, with multiple avenues now available for registering and disseminating systematic review protocols,[33, 34] disseminating reports of systematic reviews, and sharing data and materials, such as preprint servers and publicly accessible repositories.”
§ The PRISMA 2020 statement: An updated guideline for reporting systematic reviews > Abstract
What the sources say
- Supportedcites [33] A Booth, 2012, The nuts and bolts of PROSPERO: an international prospective register of systematic reviews, Syst Rev source
The citation is attached to the clause about registering and disseminating systematic review protocols. The Background describes PROSPERO as a prospective register; the PROSPERO registration form section describes dissemination through a journal, organizational websites, and PDFs hosted by the register. The later clauses about review reports and data sharing are not attached to this citation. (LLM, conf=0.88)
- Supportedcites [34] D Moher, 2012, Establishing a new journal for systematic review products, Syst Rev source
The citation is attached to the availability of avenues for registering and disseminating systematic review protocols. The paper describes both the PROSPERO protocol register and its journal’s publication of protocols (Abstract, passage 2); the later references to preprint servers and repositories are outside the cited portion. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We identified possible modifications to the PRISMA 2009 statement by reviewing 60 documents providing reporting guidance for systematic reviews (including reporting guidelines, handbooks, tools, and meta-research studies).[38]”
§ The PRISMA 2020 statement: An updated guideline for reporting systematic reviews > Development of PRISMA 2020
What the sources say
- Partly supportedcites [38] MJ Page, 2020, Mapping of reporting guidance for systematic reviews and meta-analyses generated a comprehensive item bank for future reporting guidelines, J Clin Epidemiol sourceExperimental — accuracy not yet measured
The Results report reviewing 60 sources of reporting guidance to inform changes to PRISMA 2009, including guidelines, manuals, tools, and reporting-quality studies. However, those 60 sources were presented in 56 reports, so the paper does not support describing them as 60 documents. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“new methods have been developed to assess the risk of bias in results of included studies.[28,29]”
§ The PRISMA 2020 statement: An updated guideline for reporting systematic reviews > Abstract
What the sources say
- Supportedcites [28] JAC Sterne, 2019, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ source
The Summary Points state that the authors developed and piloted RoB 2, a revised tool for assessing risk of bias in randomised trials. The Risk of bias legend specifies that its assessments concern individual results and can be used in syntheses of trials, matching the citing sentence’s reference to results of included studies. (LLM, conf=0.92)
- Supportedcites [29] JA Sterne, 2016, ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions, BMJ source
The Summary points state that the authors developed ROBINS-I to assess risk of bias in non-randomised studies of interventions. The ‘Assessing a specific study’ section says the tool makes risk-of-bias judgements for each outcome and result in a study included in a review. This paper therefore supports the claim as an example of a new method. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Evidence from observational studies suggests that use of the PRISMA 2009 statement is associated with more complete reporting of systematic reviews,[17–20] although more could be done to improve adherence to the guideline.[21]”
§ The PRISMA 2020 statement: An updated guideline for reporting systematic reviews > Abstract
What the sources say
- Supportedcites [17] MJ Page, 2016, Epidemiology and reporting characteristics of systematic reviews of biomedical research: a cross-sectional study, PLoS Med source
The Results section reports that nearly all 26 reporting characteristics were more often present in therapeutic systematic reviews that reported using PRISMA. The Discussion describes mention of PRISMA as a possible surrogate for actual use and says it appears associated with more complete reporting; the claim’s cautious wording is consistent with that limitation. (LLM, conf=0.92)
- Supportedcites [18] N Panic, 2013, Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses, PLoS One source
The Abstract Results report significantly higher adherence to the PRISMA reporting checklist after gastroenterology and hepatology journals endorsed PRISMA, and higher adherence in endorsing journals than in non-endorsing journals. This supports the hedged association with more complete reporting. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [19] RA Agha, 2016, Impact of the mandatory implementation of reporting guidelines on reporting quality in a surgical journal: A before and after study, Int J Surg source
- Not checked — no full text of the sourcecites [20] V Leclercq, 2019, Meta-analyses indexed in PsycINFO had a better completeness of reporting when they mention PRISMA, J Clin Epidemiol source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
4 more claims · 1 with their cited sources checked
Create a free account to see all 38 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In line with the methodology employed by Wallace (2003) and the guidelines for an integrative review as outlined by de Souza et al. (2010) and the PRISMA statement (Page et al., 2021), we present a wide-ranging overview”
From Post-secondary online learning in the U.S.: an integrative review of the literature on undergraduate student characteristics (2022) · cites this paper as Page et al. (2021)
The cited source says what the claim attributes to it.
In the citing paper
“This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines [15].”
From Effects of once-weekly subcutaneous retatrutide on weight and metabolic markers: A systematic review and meta-analysis of randomized controlled trials (2024) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“This study followed the PRISMA statement.”
From Ocular disorders during treatment with GLP-1 receptor agonists: a systematic review and meta-analysis of observational studies (2026) · cites this paper as Page et al., 2021
The cited source says what the claim attributes to it.
In the citing paper
“This review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Statement. 9”
From The efficacy, acceptability and safety of acceptance and commitment therapy for fibromyalgia – a systematic review and meta-analysis (2024) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“This review adheres to the Prisma 2020 Statement (Page et al., 2021).”
From Process of change and efficacy of acceptance and commitment therapy (ACT) for anxiety and depression symptoms in adolescents: A meta-analysis of randomized controlled trials. (2025) · cites this paper as Page et al., 2021
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Self-citationPreferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Self-citationPreferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Self-citationPRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565 · cited 1×
“Finally, extensions to the PRISMA 2009 statement have been developed to guide reporting of network metaanalyses,[49] meta-analyses of individual participant data,[50] systematic reviews of harms, [51] systematic reviews of diagnostic test accuracy studies, [52] and scoping reviews [53]; for these types of reviews we r…”
MethodSelf-citationPreferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Self-citationRoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
Self-citationLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Self-citationPRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 1×
“[30, 31] Furthermore, PRISMA 2020 is not intended to inform the reporting of systematic review protocols, for which a separate statement is available (PRISMA for Protocols (PRISMA-P) 2015 statement [47,48]).”
MethodSelf-citationDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329 · cited 1×
“For example, technological advances have enabled the use of natural language processing and machine learning to identify relevant evidence,[22–24] methods have been proposed to synthesise and present findings when meta-analysis is not possible or appropriate,[25–27] and new methods have been developed to assess the ri…”
MethodSelf-citation
Research works printed but not linked: 1
- A Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLoS Med, 6, e1000100, 10.1371/journal.pmed.1000100 · DOI · Paper page
Cited by
Bobrovitz, N., Ware, H., Ma, X., Li, Z., Hosseini, R., Cao, C., Selemon, A., Whelan, M., Premji, Z., Issa, H., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00801-5 · Cited by 614
Cumpston, M. S., McKenzie, J. E., Welch, V. A., & Brennan, S. E. (2022) · Journal of Public Health · doi:10.1093/pubmed/fdac036 · Cited by 464
Self-citationArdern, C. L., Büttner, F., Andrade, R., Weir, A., Ashe, M. C., Holden, S., Impellizzeri, F. M., Delahunt, E., Dijkstra, H. P., Mathieson, S., et al. (2022) · British Journal of Sports Medicine · doi:10.1136/bjsports-2021-103987 · Cited by 458
Self-citationParums, D. V. (2021) · Medical Science Monitor · doi:10.12659/msm.934475 · Cited by 399
Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
Renaud-Charest, O., Lui, L. M. W., Eskander, S., Ceban, F., Ho, R., Di Vincenzo, J. D., Rosenblat, J. D., Lee, Y., Subramaniapillai, M., & McIntyre, R. S. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.054 · Cited by 374
Metadata
- Authors
- Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., McGuinness, L. A., Stewart, L. A., Thomas, J., Tricco, A. C., Welch, V. A., Whiting, P., & Moher, D.
- Affiliations
- Monash University (AU)
- Amsterdam University Medical Centers (NL)
- Inserm (FR)
- Bond University (AU)
- The University of Texas at San Antonio Health Science Center (US)
- University of Ottawa (CA)
- McMaster University (CA)
- Oregon Health & Science University (US)
- University of York (GB)
- University of Southern Denmark (DK)
- Ottawa Hospital (CA)
- Johns Hopkins University (US)
- Brigham and Women's Hospital (US)
- University of Bristol (GB)
- University College London (GB)
- St. Michael's Hospital (CA)
- Corresponding author
- Page, Matthew J.
- ORCID
- Page, Matthew J.
- McKenzie, Joanne E.
- Bossuyt, Patrick M.
- Boutron, Isabelle
- Hoffmann, Tammy C.
- Mulrow, Cynthia D.
- Shamseer, Larissa
- Tetzlaff, Jennifer M.
- Akl, Elie A.
- Brennan, Sue E.
- Chou, Roger
- Glanville, Julie
- Grimshaw, Jeremy M.
- Hróbjartsson, Asbjørn
- Lalu, Manoj M.
- Li, Tianjing
- Loder, Elizabeth W.
- Mayo-Wilson, Evan
- McDonald, Steve
- McGuinness, Luke A.
- Stewart, Lesley A.
- Thomas, James
- Tricco, Andrea C.
- Welch, Vivian A.
- Whiting, Penny
- Moher, David
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-03-29
- Volume
- 18
- Issue
- 3
- Pages
- e1003583
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC8007028
- OpenAlex
- W3148962211
- Cited by
- 5,148
- References
- 77
- Citations by year
- 2026: 779 · 2025: 805 · 2024: 1551 · 2023: 1037 · 2022: 779 · 2021: 197
- FWCI
- 37.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Bond University Research Portal (Bond University) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by)
- Funders
- University of Ottawa (Tier 1)
- National Institute for Health and Care Research (DRF-2018-11-ST2-048)
- National Institutes of Health (Tier 2)
- Medical Research Council
- Australian Research Council (DE200101618)
- National Health and Medical Research Council (1088535, 1154607, 1143429)
- National Eye Institute (UG1EY020522)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Social Sciences › Sociology and Political Science › Delphi Technique in Research
- Keywords
- PRISMA 2020, reporting guidelines, systematic reviews, meta-analysis, transparency, reporting quality, review methodology
- MeSH terms
- Systematic Reviews as Topic, Humans, Publishing, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. https://app.cochat.ai/papers/10.1371/journal.pmed.1003583
- The paper
- Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., . . . Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Medicine. https://doi.org/10.1371/journal.pmed.1003583
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.